Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction (vol 9, 42, 2016)

Autor: Acharya, MM, Baulch, JE, Lusardi, TA, Allen, BD, Chmielewski, NN, Baddour, AAD, Limoli, CL, Boison, D

Publikováno v: Acharya, MM; Baulch, JE; Lusardi, TA; Allen, BD; Chmielewski, NN; Baddour, AAD; et al.(2017). Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction (vol 9, 42, 2016). FRONTIERS IN MOLECULAR NEUROSCIENCE, 10. doi: 10.3389/fnmol.2017.00218. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3mw8n5p1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::49d37936e97c8272a35889e736e67bd2
http://www.escholarship.org/uc/item/3mw8n5p1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny.

Autor: Kong GL; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA., Nguyen TT; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA., Rosales WK; Earle A. Chiles Research Institute, Providence, Portland, OR, 97213, USA., Panikar AD; Knight Campus Graduate Internship Program - Bioinformatics, University of Oregon, Eugene, OR, 97403, USA., Cheney JHW; Knight Campus Graduate Internship Program - Bioinformatics, University of Oregon, Eugene, OR, 97403, USA., Lusardi TA; Cancer Early Detection Advanced Research, Oregon Health and Science University, Portland, OR, 97238, USA., Yashar WM; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA., Curtiss BM; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA., Carratt SA; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA., Braun TP; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA. braunt@ohsu.edu.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, USA. braunt@ohsu.edu., Maxson JE; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Pk. Rd., KR-HEM, Portland, OR, 97239, USA. maxsonj@ohsu.edu.

Publikováno v: BMC bioinformatics [BMC Bioinformatics] 2024 Apr 02; Vol. 25 (1), pp. 142. Date of Electronic Publication: 2024 Apr 02.

PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.

Autor: Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., VanCampen J; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Macaraeg J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Kong GL; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Taherinasab A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Tsuchiya M; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Yashar WM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Tsang YH; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Horton W; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, 97239, USA., Coleman DJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Estabrook J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, OR, 97239, USA., Lusardi TA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, OR, 97239, USA., Mills GB; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA., Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA., Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA., Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. braunt@ohsu.edu.; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, 97239, USA. braunt@ohsu.edu.; Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. braunt@ohsu.edu.

Publikováno v: Leukemia [Leukemia] 2022 Jul; Vol. 36 (7), pp. 1781-1793. Date of Electronic Publication: 2022 May 19.

Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury.

Autor: Lusardi TA; Knight Cancer Institute, Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, OR, United States., Sandau US; Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, OR, United States., Sakhanenko NA; Pacific Northwest Research Institute, Seattle, WA, United States., Baker SCB; Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, OR, United States., Wiedrick JT; Biostatistics & Design Program, Oregon Health & Science University, Portland, OR, United States., Lapidus JA; Biostatistics & Design Program, Oregon Health & Science University, Portland, OR, United States., Raskind MA; Northwest Mental Illness, Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States., Li G; Northwest Mental Illness, Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.; Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States., Peskind ER; Northwest Mental Illness, Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States., Galas DJ; Pacific Northwest Research Institute, Seattle, WA, United States., Quinn JF; Department of Neurology, Oregon Health & Science University, Portland, OR, United States.; Parkinson Center and Movement Disorders Program, School of Medicine, Oregon Health & Science University, Portland, OR, United States.; Portland VAMC Parkinson's Disease Research, Education, and Clinical Center, Portland, OR, United States., Saugstad JA; Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, OR, United States.

Publikováno v: Frontiers in neuroscience [Front Neurosci] 2021 Sep 09; Vol. 15, pp. 720778. Date of Electronic Publication: 2021 Sep 09 (Print Publication: 2021).